Stocksigma LogoStocksigma Logo

Dr. Lal PathLabs Reports Strong Q2 FY27 Results and Declares Interim Dividend

Dr. Lal PathLabs reported consolidated revenue of INR 8,739 Mn for the quarter ended 30th Sep'26, up 19.6% YoY and 9.6% QoQ

Dr. Lal PathLabs Reports Strong Q2 FY27 Results and Declares Interim Dividend

Dr. Lal PathLabs Ltd 路 Dividend 路 04 Nov 2026, 7:05 pm

Dr. Lal PathLabs Reports Strong Q2 FY27 Results and Declares Interim Dividend Dr. Lal PathLabs reported consolidated revenue of INR 8,739 Mn for the quarter ended 30th Sep'26, up 19.6% YoY and 9.6% QoQ. Consolidated net profit rose 27.4% YoY and 13.7% QoQ to INR 1,939 Mn. Basic EPS stood at INR 11.51 versus INR 9.03 in the year-ago period. The board declared a second interim dividend of INR 5 per share (50% on face value of INR 10) with a record date of 11th Nov'26, and approved investing up to INR 49.5 Cr in wholly owned subsidiary LPL Dubai.

Original exchange filing (PDF)

More announcements from Dr. Lal PathLabs Ltd

  • Attached 路 11 Nov 2026
  • Attached 路 10 Nov 2026
  • Attached 路 05 Nov 2026
  • Attached 路 04 Nov 2026
  • Attached 路 04 Nov 2026
  • Attached 路 04 Nov 2026
  • Dr. Lal Path Labs Ltd. has informed the Exchange regarding Appointment of Ms Vasuta Agarwal as Additional Director designated as Non- Executive Independent Director of the company w.e.f. November 04, 2026. 路 04 Nov 2026
  • Attached 路 04 Nov 2026

All Dr. Lal PathLabs Ltd announcements